Ignite Creation Date:
2025-12-25 @ 12:27 AM
Ignite Modification Date:
2025-12-25 @ 10:33 PM
Study NCT ID:
NCT04423367
Status:
COMPLETED
Last Update Posted:
2024-11-18
First Post:
2020-06-05
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Bortezomib Plus Dexamethasone for Acquired Pure Red Cell Aplasia Failure or Relapse After First-line Treatment
Sponsor:
Institute of Hematology & Blood Diseases Hospital, China
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-09-13
Start Date Type:
ACTUAL
Primary Completion Date:
2024-07-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-09-30
Completion Date Type:
ACTUAL
First Submit Date:
2020-06-05
First Submit QC Date:
None
Study First Post Date:
2020-06-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-11-15
Last Update Post Date:
2024-11-18
Last Update Post Date Type:
ACTUAL